Website & contact details
- Group website
- The site of this company’s group or brand.
Bioscript Stirling Limited
- Incorporated
- 17 January 2002 (24 years)
- Previously known as
- Stirlingword Limited (until 15 February 2007)Hajco 240 Limited (until 5 February 2002)
- Industry
- Management consultancy activities other than financial management (70229)
- Directors
- Owned by
- Accounts type
- Full
- Region
- North West
- Address
- Suite AGreenway House Larkwood WayTytherington Business ParkMacclesfieldSK10 2XR
Filing status
- Accounts due
- 30 June 2027
- Last accounts
- 30 September 2025
- Conf. stmt due
- 6 February 2027
- Last conf. stmt
- 23 January 2026
Charges
- Total
- 3
- Outstanding
- 2
- Part satisfied
- 0
- Satisfied
- 1
Officers 2 active
Officer details are public data from the Companies House register.
Director · Appointed 15 February 2024
British
Born December 1984 (41)
Director · Appointed 15 February 2024
British
Born September 1973 (53)
Officer history (10 former)
19 April 2024
19 April 2024
15 February 2024
15 February 2024
18 September 2019
19 February 2015
Resigned Walker, Steven James, Dr as Director
6 April 2013
6 April 2009
31 May 2008
30 March 2008
25 March 2008
Resigned Stirling, Jane, Dr as Director
25 January 2007
25 January 2007
25 January 2007
Appointed Walker, Steven James, Dr as Director
25 January 2007
14 February 2002
14 February 2002
Appointed Stirling, Jane, Dr as Director
14 February 2002
14 February 2002
14 February 2002
17 January 2002
17 January 2002
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 17 January 2017
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Limited Company
Reg. no. 09542360
Group structure 13 shown
Ownership group derived from the Companies House PSC register
Bioscript Limited Owns 75–100% of shares
Azimuth Pharma Limited Owns 75–100% of shares
Fortis Pharma Consulting Limited Owns 75–100% of shares
Bioscript Group Limited Owns 75–100% of shares
Bioscript Stirling Limited This company Owns 75–100% of shares
Medologie Limited Owns 75–100% of shares
Enzyme Communications Ltd Owns 75–100% of shares
Meridian Healthcomms Holdings Limited Owns 75–100% of shares
Cancer Communications and Consultancy Limited Owns 75–100% of shares
Meridian Healthcomms Limited Owns 75–100% of shares
Triducive Partners Limited Owns 75–100% of shares
Valid Insight Ltd Owns 75–100% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 30 September 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £8,817,593
- Cash
- £808,495
- Turnover
- £11,925,040
- Profit Before Tax
- £3,137,745
- Employees
- 98
- Debt Ratio
- 51%
- Current Ratio
- 2.0x
- Profit Margin
- 26%
- Return on Equity
- 34%
Trend
Turnover
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £160,976 | £241,095 | £129,825 | £104,116 | £110,146 | £137,606 |
| Current Assets | £17,784,130 | £10,935,545 | £7,092,542 | £4,292,592 | £4,763,971 | £3,621,128 |
| Cash | £808,495 | £432,212 | £470,581 | £598,438 | £1,311,243 | £740,409 |
| Creditors (< 1 year) | £9,096,450 | £5,323,961 | £2,858,027 | £1,746,267 | £2,164,494 | £2,378,164 |
| Net Current Assets | £8,687,680 | £5,611,584 | £4,234,515 | £2,546,325 | £2,599,477 | £1,242,964 |
| Net Assets | £8,817,593 | £5,800,532 | £4,340,429 | £2,633,183 | £2,695,574 | £1,360,082 |
| Shareholder Funds | £8,817,593 | £5,800,532 | £4,340,429 | £2,633,183 | £2,695,574 | £1,360,082 |
| Turnover | £11,925,040 | £11,010,798 | £10,537,433 | £9,925,256 | ||
| Cost of Sales | £6,369,550 | £6,634,229 | £6,463,062 | £6,008,457 | ||
| Gross Profit | £5,555,490 | £4,376,569 | £4,074,371 | £3,916,799 | ||
| Admin Expenses | £3,013,146 | £2,871,688 | £2,183,963 | £2,464,091 | ||
| Staff Costs | £5,396,032 | £5,350,219 | £5,328,355 | £4,853,118 | ||
| Operating Profit | £3,138,316 | £1,504,881 | £2,089,597 | £1,452,708 | ||
| Profit Before Tax | £3,137,745 | £1,504,881 | £2,089,597 | £1,452,708 | ||
| Tax | £120,684 | £44,778 | £382,351 | £3,209 | ||
| Profit for Period | £3,017,061 | £1,460,103 | £1,707,246 | £1,449,499 | ||
Filings 119
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 27 June 2026 | Full accounts | 30 September 2025 | ||
| 27 May 2026 | Satisfaction of a charge in full | |||
| 1 May 2026 | Registration of a charge | |||
| 6 February 2026 | Change of details for a person with significant control | |||
| 5 February 2026 | Confirmation statement with no updates | 23 January 2026 |
Some other companies at this address
Other companies in this industry
London
Newcastle-Under-Lyme
London
6-10 Kirby Street
Runcorn
By trade and location
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →